Q3 2024 Holdings
Filed 2024-11-14 | 33 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $511.5M | 5,000,000 | 17.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $334.0M | 4,000,000 | 11.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $260.4M | 480,374 | 8.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $241.0M | 5,314,089 | 8.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $128.6M | 2,516,686 | 4.4% |
| Merus N V | COM | N5749R100 | $122.6M | 2,454,917 | 4.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $109.1M | 2,400,574 | 3.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $84.6M | 4,331,321 | 2.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $80.3M | 2,440,445 | 2.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $74.4M | 2,789,172 | 2.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $73.6M | 1,497,720 | 2.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $71.7M | 627,732 | 2.4% |
| Arcellx Inc(ACLX)Call | COMMON STOCK | 03940C100 | $66.8M | 800,000 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $65.9M | 2,895,689 | 2.2% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $65.7M | 5,503,600 | 2.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $57.6M | 2,339,961 | 1.9% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $53.7M | 4,086,346 | 1.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $49.8M | 4,609,762 | 1.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $48.5M | 1,096,851 | 1.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $47.0M | 931,480 | 1.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $45.0M | 200,336 | 1.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $44.6M | 3,904,862 | 1.5% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $41.2M | 701,817 | 1.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $38.9M | 1,362,827 | 1.3% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $38.9M | 2,321,013 | 1.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $37.3M | 1,267,581 | 1.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $34.8M | 3,104,486 | 1.2% |
| Vaxcyte Inc(PCVX)Call | COM | 92243G108 | $31.6M | 276,800 | 1.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $30.5M | 525,037 | 1.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $29.1M | 10,668,141 | 1.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $17.6M | 719,660 | 0.6% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $12.3M | 919,692 | 0.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $7.3M | 1,160,000 | 0.2% |